North Crest Asset Manangement, LLC Laboratory Corp Of America Holdings Transaction History

North Crest Asset Manangement, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$209.01 - $232.56 $76,497 - $85,116	366 Added 0.97%	38,025 $8.31 Million
Q4 2023 Jan 30, 2024	SELL	$197.69 - $227.29 $26,095 - $30,002	-132 Reduced 0.35%	37,659 $8.56 Million
Q3 2023 Nov 13, 2023	SELL	$201.05 - $221.7 $26,538 - $29,264	-132 Reduced 0.35%	37,791 $7.6 Million
Q2 2023 Jul 21, 2023	SELL	$211.93 - $241.33 $38,571 - $43,922	-182 Reduced 0.48%	37,923 $9.15 Million
Q1 2023 Apr 25, 2023	BUY	$213.32 - $257.83 $8.13 Million - $9.82 Million	38,105 New	38,105 $8.74 Million
Q4 2022 Feb 01, 2023	SELL	$203.72 - $248.97 $498,299 - $608,980	-2,446 Reduced 6.17%	37,195 $8.75 Million
Q3 2022 Oct 17, 2022	BUY	$204.81 - $262.19 $8.12 Million - $10.4 Million	39,641 New	39,641 $8.12 Million
Q2 2022 Jul 18, 2022	SELL	$213.86 - $277.87 $8.18 Million - $10.6 Million	-38,268 Closed	0 $0
Q1 2022 Apr 18, 2022	SELL	$259.82 - $298.18 $278,007 - $319,052	-1,070 Reduced 2.72%	38,268 $10.1 Million
Q4 2021 Feb 09, 2022	BUY	$271.6 - $314.21 $10.7 Million - $12.4 Million	39,338 New	39,338 $12.4 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

Stay updated on North Crest Asset Manangement, LLC with notifications on news.